PW Medtech Group Limited

SEHK:1358 Stock Report

Market Cap: HK$1.5b

PW Medtech Group Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Yue'e Zhang

Chief executive officer

CN¥1.1m

Total compensation

CEO salary percentage100.0%
CEO tenure5.8yrs
CEO ownershipn/a
Management average tenure5yrs
Board average tenure11.4yrs

Recent management updates

Here's Why PW Medtech Group Limited's (HKG:1358) CEO Might See A Pay Rise Soon

Jun 07
Here's Why PW Medtech Group Limited's (HKG:1358) CEO Might See A Pay Rise Soon

Recent updates

PW Medtech Group's (HKG:1358) Solid Earnings Are Supported By Other Strong Factors

Sep 26
PW Medtech Group's (HKG:1358) Solid Earnings Are Supported By Other Strong Factors

Here's Why PW Medtech Group Limited's (HKG:1358) CEO Might See A Pay Rise Soon

Jun 07
Here's Why PW Medtech Group Limited's (HKG:1358) CEO Might See A Pay Rise Soon

There's Reason For Concern Over PW Medtech Group Limited's (HKG:1358) Price

Mar 14
There's Reason For Concern Over PW Medtech Group Limited's (HKG:1358) Price

We Think PW Medtech Group (HKG:1358) Can Manage Its Debt With Ease

Nov 23
We Think PW Medtech Group (HKG:1358) Can Manage Its Debt With Ease

How Much Have PW Medtech Group (HKG:1358) Shareholders Earned On Their Investment Over The Last Five Years?

Feb 18
How Much Have PW Medtech Group (HKG:1358) Shareholders Earned On Their Investment Over The Last Five Years?

Should You Rely On PW Medtech Group's (HKG:1358) Earnings Growth?

Jan 23
Should You Rely On PW Medtech Group's (HKG:1358) Earnings Growth?

Here's Why PW Medtech Group (HKG:1358) Can Manage Its Debt Responsibly

Dec 28
Here's Why PW Medtech Group (HKG:1358) Can Manage Its Debt Responsibly

Should You Be Adding PW Medtech Group (HKG:1358) To Your Watchlist Today?

Dec 10
Should You Be Adding PW Medtech Group (HKG:1358) To Your Watchlist Today?

What You Need To Know About PW Medtech Group Limited's (HKG:1358) Investor Composition

Nov 22
What You Need To Know About PW Medtech Group Limited's (HKG:1358) Investor Composition

CEO Compensation Analysis

How has Yue'e Zhang's remuneration changed compared to PW Medtech Group's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

CN¥152m

Mar 31 2024n/an/a

CN¥153m

Dec 31 2023CN¥1mCN¥1m

CN¥153m

Sep 30 2023n/an/a

CN¥135m

Jun 30 2023n/an/a

CN¥116m

Mar 31 2023n/an/a

CN¥111m

Dec 31 2022CN¥1mCN¥1m

CN¥106m

Sep 30 2022n/an/a

CN¥72m

Jun 30 2022n/an/a

CN¥39m

Mar 31 2022n/an/a

CN¥389m

Dec 31 2021CN¥1mCN¥1m

CN¥739m

Sep 30 2021n/an/a

CN¥995m

Jun 30 2021n/an/a

CN¥1b

Mar 31 2021n/an/a

CN¥942m

Dec 31 2020CN¥1mCN¥1m

CN¥632m

Sep 30 2020n/an/a

CN¥398m

Jun 30 2020n/an/a

CN¥163m

Mar 31 2020n/an/a

CN¥123m

Dec 31 2019CN¥1mCN¥1m

CN¥82m

Jun 30 2019n/an/a

CN¥136m

Mar 31 2019n/an/a

CN¥126m

Dec 31 2018CN¥995kCN¥995k

CN¥115m

Compensation vs Market: Yue'e's total compensation ($USD145.49K) is below average for companies of similar size in the Hong Kong market ($USD348.23K).

Compensation vs Earnings: Yue'e's compensation has been consistent with company performance over the past year.

CEO

Yue'e Zhang (61 yo)

5.8yrs

Tenure

CN¥1,062,000

Compensation

Ms. Yue'e Zhang has been Chief Executive Officer at PW Medtech Group Ltd. since March 31, 2019. Ms. Zhang serves as a General Manager, Senior Engineer and Executive Director of WP Medical Technologies, Inc...

Leadership Team

NamePositionTenureCompensationOwnership
Yue'e Zhang
Executive Chairman & CEO5.8yrsCN¥1.06mno data
Tian Tian
Financial Director5yrsno datano data
Ka Man So
Company Secretary2.4yrsno datano data

5.0yrs

Average Tenure

50yo

Average Age

Experienced Management: 1358's management team is seasoned and experienced (5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Yue'e Zhang
Executive Chairman & CEO13.7yrsCN¥1.06mno data
Xiaogang Wang
Independent Non-Executive Director11.3yrsCN¥181.00kno data
Geng Chen
Independent Non-Executive Director11.3yrsCN¥181.00k0.043%
HK$ 630.2k
Liwei Jiang
Non-Executive Director11.6yrsCN¥300.00k0.18%
HK$ 2.6m
Junshan Lin
Non-Executive Director11.6yrsCN¥300.00k0.11%
HK$ 1.7m
Fengli Wang
Independent Non-Executive Director3.4yrsCN¥181.00kno data

11.4yrs

Average Tenure

59yo

Average Age

Experienced Board: 1358's board of directors are seasoned and experienced ( 11.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 01:52
End of Day Share Price 2025/01/02 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

PW Medtech Group Limited is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jessica LiBofA Global Research
Kevin LeungHaitong International Research Limited (Inactive)
Bin LiMorgan Stanley